Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies today announced Amgen’s equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology.
October 18, 2018
· 8 min read